Channels - Balancing the complex interplay between type 2 immunity‐targeting biologics and autoimmune phenomena in real‐world practice :: FRELIP Discovery

Similar Items: Balancing the complex interplay between type 2 immunity‐targeting biologics and autoimmune phenomena in real‐world practice

Quick Look
Association of autoimmune diseases with biologic agents targeting type 2 immunity: An observational study using a claims database
Quick Look
Epstein‐Barr virus as a driver of lupus: Rethinking triggers in autoimmunity
Quick Look
Management of interstitial lung disease in systemic autoimmune rheumatic diseases: a survey of rheumatologists and pulmonologists
Quick Look
Golimumab for the Treatment of Rheumatoid Arthritis: A Narrative Review of Pivotal Randomized Trials and Real-World Studies
Quick Look
Impact of biological/targeted versus conventional synthetic disease‐modifying antirheumatic drugs on patient‐reported outcomes in rheumatoid arthritis
Quick Look
Comparative Effectiveness of Upadacitinib vs. Other JAK Inhibitors in Patients With Rheumatoid Arthritis in a Global Real-World Setting
Quick Look
From Nerve to Autoimmunity: Acute Guillain-Barré Syndrome in a 4-Year-Old with Early-Onset Pediatric Systemic Lupus Erythematosus
Quick Look
Efficacy/Effectiveness, Safety and Treatment Persistence of Filgotinib in Rheumatoid Arthritis: A Narrative Review of Clinical Trials and Real-World Evidence
Quick Look
Real-world experience with Janus kinase inhibitors in rheumatoid and psoriatic arthritis: retention and discontinuation factors in a UK six-centre cohort
Quick Look
Real-World Upadacitinib Persistence and Clinical Outcomes Among Canadian Patients with Inflammatory Arthritis from a Patient Support Program: The UPRAISE Study
Quick Look
Achievement and Maintenance of Remission with Upadacitinib in Patients with Moderate-to-Severe Rheumatoid Arthritis in Italy: 1-Year Data from UPHOLD, a Prospective Real-World Observational Study
Quick Look
Shingles vaccination before targeted therapy: why clear guidance isn’t enough
Quick Look
Causal relationship between immune cells and idiopathic thrombocytopenic purpura: A bidirectional Mendelian randomization study
Quick Look
Identification of Key Glycolysis-Related Genes in Osteoarthritis and Their Correlation with Immune Infiltration Using Bioinformatics Analysis and Machine Learning
Quick Look
Corrigendum “immune cell alterations in a pristane‐induced lupus model in C57BL/6J mice”
Quick Look
Towards a cure for gout: A two‑stage treat‐to‐target strategy from inflammation control to structural remission
Quick Look
The Risk of Developing Immune-Mediated Rheumatic Disease Among Adult Patients with Temporomandibular Disorders, a Retrospective Single-Center Cohort Study
Quick Look
Biologic Therapy Is Associated with Faster Bone Union After the Sauvé–Kapandji Procedure in Patients with Rheumatoid Arthritis
Quick Look
Decision on Optimal Combinatorial Therapies in Immune-mediated inflammatory diseases using Systems approaches (DocTIS): protocol for a single-arm, adaptive basket trial in rheumatoid and psoriatic arthritis
Quick Look
Type I interferon overactivation in sera of patients with anti‐MDA5‐positive dermatomyositis‐associated interstitial lung disease
Quick Look
Robotic-Assisted Total Knee Arthroplasty in Complex Primary and Revision Cases: A Systematic Review
Quick Look
Farnesoid X receptor prevents hyperuricemia via activating ATP‐binding cassette subfamily G member 2
Quick Look
Anti-NXP2 antibody-positive dermatomyositis presenting as systemic capillary leak syndrome with cutaneous and gastrointestinal ulcers
Quick Look
EBV-positive diffuse large B-cell lymphoma with central nervous system involvement in Anti-Mi-2-positive dermatomyositis